---
title: "Chemed Q2 FY26 GAAP diluted EPS climbs 43.7% to $5.13; revenue increases 8.8% to $673.3 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294110404.md"
description: "Chemed reported Q2 FY26 GAAP diluted EPS of $5.13, up 43.7%, with revenue rising 8.8% to $673.3 million. VITAS net patient revenue grew 11.9% to $443.3 million, while Roto-Rooter revenue increased 3.3% to $229.9 million. Driven by VITAS outperformance, Chemed raised its 2026 adjusted diluted EPS guidance to $25.00-$25.75 from the previous range."
datetime: "2026-07-28T20:32:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294110404.md)
  - [en](https://longbridge.com/en/news/294110404.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294110404.md)
---

# Chemed Q2 FY26 GAAP diluted EPS climbs 43.7% to $5.13; revenue increases 8.8% to $673.3 million

-   Chemed posted Q2 revenue of $673.3 million, up 8.8%, with GAAP diluted EPS of $5.13, up 43.7%. \* VITAS net patient revenue climbed 11.9% to $443.3 million; average daily census rose 6.1% to 23,687. \* VITAS recorded $500,000 in Medicare Cap billing limitation versus $16.4 million a year earlier; no Florida cap is expected in 2026. \* Roto-Rooter revenue increased 3.3% to $229.9 million; adjusted EBITDA was $48.5 million, essentially flat, with margin down 0.77 percentage point to 21.1%. \* 2026 adjusted diluted EPS guidance increased to $25.00-$25.75 from $24.00-$24.75, mainly on VITAS outperformance; Roto-Rooter outlook unchanged. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chemed Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000019584-26-000018), on July 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CHE.US](https://longbridge.com/en/quote/CHE.US.md)

## Related News & Research

- [Chemed (NYSE:CHE) Posts Earnings Results](https://longbridge.com/en/news/294127496.md)
- [Chemed Q2 revenue beats estimates, helped by VITAS segment growth](https://longbridge.com/en/news/294109919.md)
- [Chemed Corporation (NYSE:CHE) Given Consensus Rating of "Hold" by Analysts](https://longbridge.com/en/news/294342032.md)
- [CHE: Strong VITAS results and share buybacks drove higher earnings and raised full-year guidance](https://longbridge.com/en/news/294110841.md)
- [Chemed Corporation $CHE Stock Position Cut by NewEdge Wealth LLC](https://longbridge.com/en/news/294034590.md)